Suzuken Co Ltd represents values of trust, integrity, and innovation. The company's corporate philosophy is focused on contributing to society through its healthcare business. Suzuken Co Ltd strives to provide high-quality products and services that improve the well-being and health of individuals. With a strong commitment to ethical business practices, Suzuken Co Ltd continually seeks to meet the evolving needs of customers and stakeholders, fostering long-term partnerships built on reliability and excellence. Through its dedication to advancing healthcare solutions, Suzuken Co Ltd aims to create a healthier and more prosperous future for all.

Suzuken Co Ltd is primarily present in Japan.

Suzuken Co Ltd, a leading stock, has achieved several significant milestones over the years. One milestone is its successful expansion into the global market, establishing a strong presence in various countries. Suzuken has also demonstrated consistent growth through strategic partnerships and mergers, enhancing its product portfolio and market position. Moreover, the company has received recognition for its commitment to innovation and quality, earning prestigious industry awards. Suzuken's consistent financial performance and ability to adapt to evolving market trends further highlight its success as a trusted player in the stock industry. As a result, Suzuken Co Ltd continues to secure its position as a market leader, driving value and growth for its shareholders.

Suzuken Co Ltd is a renowned Japanese company with a rich history and background. Established in 1921, Suzuken initially operated as a wholesale distributor for pharmaceutical products. Over the years, the company expanded its operations and diversified its portfolio. Today, Suzuken Co Ltd is a leading provider of comprehensive healthcare services, including pharmaceutical distribution, home healthcare, clinical diagnostics, and healthcare IT solutions. The company's commitment to innovation and customer-centric approach has propelled its growth and reputation in the industry. With a strong presence in Japan and expanding globally, Suzuken Co Ltd continues to play a crucial role in shaping the future of healthcare delivery.

The main competitors of Suzuken Co Ltd in the market include McKesson Corporation, AmerisourceBergen Corporation, and Cardinal Health Inc. These companies are global pharmaceutical wholesale distributors that operate in a similar industry as Suzuken. McKesson Corporation, based in the United States, is one of the largest healthcare services and information technology companies. AmerisourceBergen Corporation, also based in the United States, is a leading provider of pharmaceutical distribution and related healthcare services. Cardinal Health Inc. is another prominent player in the healthcare services and products sector, with operations in over 60 countries.

Suzuken Co Ltd is primarily active in the pharmaceutical industry.

The business model of Suzuken Co Ltd revolves around the distribution and sales of pharmaceutical and medical products in Japan. As a leading company in the healthcare industry, Suzuken operates through various segments including Pharmaceutical Wholesale, Pharmacy Chain, Medical Instruments and Equipment, and Home Healthcare. Suzuken collaborates with manufacturers to procure and distribute a wide range of pharmaceutical products to hospitals, clinics, and pharmacies across Japan. The company aims to enhance healthcare accessibility by providing high-quality medical supplies and services to customers. Suzuken's comprehensive business model enables it to contribute effectively to the healthcare system and meet the evolving needs of the Japanese market.

Suzuken Co hissesinin F/K oranı 15,02.

Suzuken Co KUV 0,18 dir.

Suzuken Co için AlleAktien Kalite Skoru 4/10'dur.

Suzuken Co cirosu 2,39 Bio. JPY dir.

Suzuken Co karı 29,02 Milyar JPY olarak gerçekleşmiştir.

Suzuken Co Ltd is a Japanese company specializing in the sale and distribution of pharmaceuticals, medical devices, and diagnostic tests. The company was founded in 1934 and is headquartered in Kyoto, Japan. It operates in various segments, including pharmaceutical supply, medical device trading, diagnostic tests, and other business areas such as health and care products and the Suzuken Pharmacy chain. Suzuken has partnerships with international companies to meet the global demand for its products. It has made acquisitions and partnerships in recent years to expand its business activities and has focused on developing innovative services and technologies. Overall, Suzuken is a key player in the Japanese healthcare industry and is well-positioned to grow and expand its business in the future.

Suzuken Co, yılda kez dağıtılmak üzere 72,00 JPY tutarında temettü ödemektedir.

Suzuken Co için şu an için temettü hesaplanamıyor veya şirket temettü dağıtmıyor.

Suzuken Co şirketinin ISIN kodu JP3398000004’dir.

Suzuken Co 'nin WKN'si 914027 'dir.

Suzuken Co için Ticker 9987.T’dir.

Son 12 ay içerisinde Suzuken Co, 90,00 JPY tutarında bir temettü ödedi. Bu, yaklaşık olarak 1,67 % oranında bir temettü verimine denk gelmektedir. Gelecek 12 ay için Suzuken Co, tahmini olarak 91,58 JPY tutarında bir temettü ödemesi yapacak.

Suzuken Co şirketinin mevcut temettü verimi 1,67 %.

Suzuken Co dönemsel olarak temettü ödemesi yapar. Bu ödemeler Ekim, Nisan, Ekim, Nisan aylarında gerçekleştirilir.

Suzuken Co, son 23 yıl içerisinde her yıl temettü ödedi.

Önümüzdeki 12 ay için 91,58 JPY tutarında temettü ödenmesi beklenmektedir. Bu, 1,70 % oranında bir temettü verimidir.

Suzuken Co, 'Sağlık' sektörüne atanmıştır.

Son Suzuken Co tarihinde 50 JPY tutarındaki en son temettüyü alabilmek için, hisseyi 27.09.2024 tarihindeki Ex-Tag'den önce portföyünde bulundurman gerekiyordu.

Son ödeme tarihi 01.12.2024 olarak gerçekleşti.

2023 yılında Suzuken Co tarafından 76 JPY olarak temettüler dağıtıldı.

Suzuken Co hisselerinin temettüleri JPY olarak dağıtılır.